Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems

Infection and Immunity

Volumn 71, Issue 9, 2003, Pages 4961-4969

  Yadava, Anjali ^a,b   Ockenhouse, Christian F ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Department of Immunology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE BINDING ANTIGEN 175; ERYTHROCYTE BINDING ANTIGEN F2 VACCINE; GLYCOPHORIN A; GLYCOPHORIN A RECEPTOR; LIGAND; MALARIA VACCINE; PARASITE ANTIGEN; RECOMBINANT F2 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN STRUCTURE; ARTICLE; BINDING AFFINITY; CELL INCLUSION; CELL INVASION; CODON; CODON USAGE; DRUG POTENCY; ERYTHROCYTE; ESCHERICHIA COLI; EUKARYOTE; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; GENE TECHNOLOGY; GENETIC RECOMBINATION; IMMUNOFLUORESCENCE; LIGAND BINDING; MALARIA; MEROZOITE; MOLECULAR CLONING; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITOSIS; PICHIA PASTORIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROKARYOTE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RECEPTOR BINDING; SPOROZOITE; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CARRIER PROTEINS; CODON; ERYTHROCYTES; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENES, PROTOZOAN; HUMANS; MALARIA VACCINES; MICE; MOLECULAR SEQUENCE DATA; PICHIA; PLASMODIUM FALCIPARUM; PROTEIN FOLDING; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; VACCINES, SYNTHETIC;

EID: 0042324336     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.9.4961-4969.2003     Document Type: Article

References (32)

1. Adams, J. H., B. K. Sim, S. A. Dolan, X. Fang, D. C. Kaslow, and L. H. Miller. 1992. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. USA 89:7085-7089.
2. Baird, J. K. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11:105-111.
3. Brady, C. P., R. L. Shimp, A. P. Miles, M. Whitmore, and A. W. Stowers. 2001. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Protein Expr. Purif. 23:468-475.
4. Camus, D., and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230:553-556.
5. Carrio, M. M., and A. Villaverde. 2002. Construction and deconstruction of bacterial inclusion bodies. J. Biotechnol. 96:3-12.
6. Chakraborty, S., B. Sarmah, N. Chakraborty, and A. Dutta. 2002. Premature truncation of RNA polymerase II mediated transcription of a seed protein in Schizosaccharomyces pombe. Nucleic Acids Res. 30:2940-2949.
7. Cohen, S., G. A. Butcher, and R. B. Crandall. 1969. Action of malarial antibody in vitro. Nature 223:368-371.
8. Dolan, S. A., J. L. Proctor, D. W. Alling, Y. Okubo, T. E. Wellems, and L. H. Miller. 1994. Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol. Biochem. Parasitol. 64:55-63.
9. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, I. T. Paulsen, K. James, J. A. Eisen, K. Rutherford, S. L. Salzberg, A. Craig, S. Kyes, M. S. Chan, V. Nene, S. J. Shallom, B. Suh, J. Peterson, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, D. Haft, M. W. Mather, A. B. Vaidya, D. M. Martin, A. H. Fairlamb, M. J. Fraunholz, D. S. Roos, S. A. Ralph, G. I. McFadden, L. M. Cummings, G. M. Subramanian, C. Mungall, J. C. Venter, D. J. Carucci, S. L. Hoffman, C. Newbold, R. W. Davis, C. M. Fraser, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
10. Gowda, D. C., and E. A. Davidson. 1999. Protein glycosylation in the malaria parasite. Parasitol. Today. 15:147-152.
11. Gruner, A. C., K. Brahimi, F. Letourneur, L. Renia, W. Eling, G. Snounou, and P. Druilhe. 2001. Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J Infect. Dis. 184:892-897.
12. Haynes, J. D., C. L. Diggs, F. A. Hines, and R. E. Desjardins. 1976. Culture of human malaria parasite Plasmodium falciparum. Nature 263:767-769.
13. Jones, T. R., D. L. Narum, A. S. Gozalo, J. Aguiar, S. R. Fuhrmann, H. Liang, J. D. Haynes, J. K. Moch, C. Lucas, T. Luu, A. J. Magill, S. L. Hoffman, and B. K. Sim. 2001. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J. Infect. Dis. 183:303-312.
14. Kane, J. F. 1995. Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol. 6:494-500.
15. Kennedy, M. C., J. Wang, Y. Zhang, A. P. Miles, F. Chitsaz, A. Saul, C. A. Long, L. H. Miller, and A. W. Stowers. 2002. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70:6948-6960.
16. Kocken, C. H., M. A. Dubbeld, A. Van Der Wel, J. T. Pronk, A. P. Waters, J. A. Langermans, and A. W. Thomas. 1999. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect. Immun. 67:43-49.
17. Kocken, C. H., C. Withers-Martinez, M. A. Dubbeld, A. van der Wel, F. Hackett, A. Valderrama, M. J. Blackman, and A. W. Thomas. 2002. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect. Immun. 70:4471-4476.
18. Liang, H., and B. K. Sim. 1997. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol. Biochem. Parasitol. 84:241-245.
19. Makhoul, C. H., and E. N. Trifonov. 2002. Distribution of rare triplets along mRNA and their relation to protein folding. J. Biomol. Struct. Dyn. 20:413-420.
20. Michon, P., J. R. Stevens, O. Kaneko, and J. H. Adams. 2002. Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites. Mol. Biol. Evol. 19:1128-1142.
21. Miles, A. P., Y. Zhang, A. Saul, and A. W. Stowers. 2002. Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials. Protein Expr. Purif. 25:87-96.
22. Morgan, W. D., B. Birdsall, T. A. Frenkiel, M. G. Gradwell, P. A. Burghaus, S. E. Syed, C. Uthaipibull, A. A. Holder, and J. Feeney. 1999. Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. J. Mol. Biol. 289:113-122.
23. Narum, D. L., J. D. Haynes, S. Fuhrmann, K. Moch, H. Liang, S. L. Hoffman, and B. K. Sim. 2000. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect. Immun. 68:1964-1966.
24. Ockenhouse, C. F., A. Barbosa, D. P. Blackall, C. I. Murphy, O. Kashala, S. Dutta, D. E. Lanar, and J. R. Daugherty. 2001. Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to glycophorin A. Mol. Biochem. Parasitol. 113:9-21.
25. Okenu, D. M., E. M. Riley, Q. D. Bickle, P. U. Agomo, A. Barbosa, J. R. Daugherty, D. E. Lanar, and D. J. Conway. 2000. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect. Immun. 68:5559-5566.
26. Pandey, K. C., S. Singh, P. Pattnaik, C. R. Pillai, U. Pillai, A. Lynn, S. K. Jain, and C. E. Chitnis. 2002. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol. Biochem. Parasitol. 123:23-33.
27. Sabchareon, A., T. Burnouf, D. Ouattara, P. Attanath, H. Bouharoun-Tayoun, P. Chantavanich, C. Foucault, T. Chongsuphajaisiddhi, and P. Druilhe. 1991. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45:297-308.
28. Sijwali, P. S., L. S. Brinen, and P. J. Rosenthal. 2001. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein Expr. Purif. 22:128-134.
29. Sim, B. K., C. E. Chitnis, K. Wasniowska, T. J. Hadley, and L. H. Miller. 1994. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264:1941-1944.
30. Smith, J. D., G. Subramanian, B. Gamain, D. I. Baruch, and L. H. Miller. 2000. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol. Biochem. Parasitol. 110:293-310.
31. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
32. Weber, J. L. 1987. Analysis of sequences from the extremely A + T-rich genome of Plasmodium falciparum. Gene 52:103-109.